CDH1 and cancer: Activated β-catenin dissociates from E-cadherin, which disassembles adherens junctions and then enters the nucleus to activate the expression of target genes, which accounts for the upregulation of EMT biomarkers and an ultimately unfavorable cancer prognosis [6, 8].